BioCentury
ARTICLE | Clinical News

F-star Alpha, Bristol-Myers preclinical data

October 12, 2015 7:00 AM UTC

In mouse models of HER2-positive colorectal or gastric cancer, once-weekly 10 mg/kg FS102 for 4-5 weeks led to complete tumor regression and no tumor regrowth was observed during a 13-week follow-up p...